Pase Pharma Private Limited - Company Profile

It is a pharma private limited company based in East Delhi, Delhi, India, established in 2004.
2004 East Delhi, Delhi, India Active
Last Updated:
Access Report
About Pase Pharma Private Limited

Pase Pharma Private Limited, a active private limited company, was established on 17 September 2004 in East Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232DL2004PTC129209. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Poonam Khandoori (Director), Anil Khanduri (Additional Director), Sunil Khanduri (Director). Past directors included Prem Ballabh, Anil Khanduri. It holds ₹0.46 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-13B, First Floor, Jhilmil, Industrial Area, East Delhi, Delhi, 110095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2004PTC129209

  • Registration Number

    129209

  • Incorporation Date

    17 September 2004

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.46 M
  • Revenue Growth **** 59.95%
  • Profit Growth **** 60.14%
  • Ebitda **** 143.16%
  • Net Worth 29.71%
  • Total Assets **** 25.36%
Company report

Pase Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Pase Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pase Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Poonam Khandoori Director 08 Apr 2019 Current
Anil Khanduri Additional Director 20 Aug 2025 Current
Sunil Khanduri Director 17 Sep 2004 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Apr 2019 Past
Pramod Abcsdd Director 18 Apr 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pase Pharma.

Pase Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.95% increase. The company also saw a substantial improvement in profitability, with a 60.14% increase in profit. The company's net worth Soared by an impressive increase of 29.71%.

Pase Pharma revenue growth over time
Pase Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 59.95%
*******
*******
*******
*******
Revenue from Operations
*******
 59.95%
*******
*******
*******
*******
Total Assets
*******
 25.36%
*******
*******
*******
*******
Profit or Loss
*******
 60.14%
*******
*******
*******
*******
Net Worth
*******
 29.71%
*******
*******
*******
*******
EBITDA
*******
 143.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pase Pharma?

In 2020, Pase Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹463,290.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
16 Jun 2024 Others ₹0.46 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Pase Pharma?

Unlock and access historical data on people associated with Pase Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pase Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pase Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pase Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Pase Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Anil Khanduri was appointed as a Additional Director was appointed as a Additional Director on 20 Aug 2025 & has been associated with this company since 8 months 27 days . was recorded as a recent event.

  • Balance Sheet

    Pase Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.46 M with Charge ID 100948121 was registered on 16 Jun 2024. was documented.

  • Director Appointment

    Poonam Khandoori was appointed as a Director was appointed as a Director on 08 Apr 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Sunil Khanduri was appointed as a Director was appointed as a Director on 17 Sep 2004 & has been associated with this company since 21 years 7 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pase Pharma Private Limited?

The CIN of Pase Pharma Private Limited is U24232DL2004PTC129209.

Where is Pase Pharma Private Limited headquartered?

Pase Pharma Private Limited is headquartered at B-13B, First Floor, Jhilmil, Industrial Area, East Delhi, Delhi, 110095.

When was Pase Pharma Private Limited incorporated?

Pase Pharma Private Limited was incorporated on 17 September 2004.

Who are the current directors of Pase Pharma Private Limited?

The current directors of Pase Pharma Private Limited are

What is the primary industry of Pase Pharma Private Limited?

The primary industry of Pase Pharma Private Limited is Trade.

Is Pase Pharma Private Limited a listed company?

Pase Pharma Private Limited is unlisted.

What is the capital structure of Pase Pharma Private Limited?

The authorized capital of Pase Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Pase Pharma Private Limited?

The compliance status of Pase Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available